The clinical use of polygenic risk scores.

Thorkild Terkelsen, Thomas Folkmann Hansen, Morten Krogh Herlin, Malene Djursby,Mette Nyegaard, Inge Søkilde Pedersen,Dorte Launholt Lildballe, Søren Lejsted Færgeman,Lone Sunde, Mads Engel Hauberg

Ugeskrift for laeger(2023)

引用 0|浏览3
暂无评分
摘要
Polygenic risk scores (PRS) identify at-risk individuals for many common diseases. A discussion of strengths and limitations is carried out in this review. PRS complement traditional genetic testing and have shown utility in establishing a proper diagnosis and guiding primary and secondary prevention. Some individuals with high PRS have risks similar to those with monogenic predisposition. Limitations include potential misinterpretations, problems with application across ancestries, and limited usefulness in low-heritability traits. Despite its shortcomings PRS are predicted to play major roles in the future of personal medicine and genetic testing.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要